drugset / Trial / NCT04260555

Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

NCT04260555 ↗

Phase 3 Unknown 204 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1601 Compared to DW16011 and DW16012 for Acute Bronchitis

Timeline

Start
2018-12-20
Primary completion
2019-12-09
Completion
2021-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject DW1601 Unknown 20 ml Oral
Comparator DW16011 Unknown 20 ml Oral
Comparator DW16012 Unknown 9 ml Oral

Indications